If you are wondering whether Amneal Pharmaceuticals at US$14.11 still offers value after a strong run, you are not alone. This article is here to help you size that up clearly. The stock has seen ...

AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Rating (Long-Term ...